Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Sialyl-di-Lewisa as expressed on glycoproteins but not glycolipids as a functional cancer target and antibodies thereto

Sialyl-di-Lewisa as expressed on glycoproteins but not glycolipids as a functional cancer target and antibodies thereto

US Patent 10835618 · Granted Nov 17, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glycans as functional cancer targets and antibodies thereto2018
Glycans as functional cancer targets and antibodies thereto2018
CD55-interaction partners and the uses thereof2017
Monoclonal antibody SC104 and derivative thereof specifically binding to a sialy2013
Binding member which binds to both lewis-Y and lewis-B haptens, and its use for 2012
Polypeptides capable of binding to CD64 comprising one or more heterologous T ce2012
Monoclonal antibody Sc104 and derivative thereof specifically binding to a sialy2011
Binding member which binds to both Lewis-y and Lewis-b haptens, and its use for 2011
Binding member which binds to both Lewisy and Lewisb haptens, and its use for tr2007